FDA broadens options for using Edwards heart valve

Published



WASHINGTON (AP) — The Food and Drug Administration said Monday that it has approved broader use of an innovative artificial heart valve that can be implanted without major surgery, allowing surgeons to insert the implant through multiple pathways.

The agency approved revised labeling for Edwards Lifesciences’ Sapien heart valve, which is approved for patients who face major risks from open-heart surgery or who are too sick to have that procedure done.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.